Are surrogates of IGHV gene mutational status useful in B-cell chronic lymphocytic leukemia? The example of Septin-10
暂无分享,去创建一个
F Forconi | G. Gaidano | V. Gattei | F. Forconi | G Gaidano | A. Zucchetto | M. Degan | D Benedetti | R Bomben | M Dal-Bo | D Marconi | A Zucchetto | M Degan | G Del-Poeta | V Gattei | D. Benedetti | R. Bomben | D. Marconi | M. Dal-Bo | G. Del-Poeta
[1] E. Ghia,et al. Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study. , 2007, Blood.
[2] Göran Roos,et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. , 2002, Blood.
[3] O. Wagner,et al. Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression , 2006, Leukemia.
[4] F. Lo Coco,et al. Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. , 2006, Blood.
[5] Nikolaos Laoutaris,et al. Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene. , 2005, Blood.
[6] H. Döhner,et al. High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia , 2005, Leukemia.
[7] Nikolaos Laoutaris,et al. Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations. , 2006, Blood.
[8] W. Graveland,et al. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia. , 2006, Haematologica.